发明授权
US08273763B2 Drugs for the treatment of sarcoglycanopathies 有权
药物治疗肌阵挛症

Drugs for the treatment of sarcoglycanopathies
摘要:
Inhibitors of the endoplasmic reticulum associated degradation (ERAD) pathway, particularly inhibitors of mannosidase I, are used to treat sarcoglycanopathies.
公开/授权文献
信息查询
0/0